AbbVie Inc. (NYSE:ABBV) Receives $210.71 Average Price Target from Analysts
AbbVie Inc. (NYSE:ABBV – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the twenty-six analysts that are presently covering the firm, MarketBeat reports. Seven investment analysts have rated the stock with a hold recommendation, sixteen have given a buy recommendation and three have issued a strong buy recommendation on the […]
AbbVie Inc. (NYSE:ABBV – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the twenty-six analysts that are presently covering the firm, MarketBeat reports. Seven investment analysts have rated the stock with a hold recommendation, sixteen have given a buy recommendation and three have issued a strong buy recommendation on the […]
